Laponite as carrier for controlled in vitro delivery of dexamethasone in vitreous humor models

Laponite clay is able to retain dexamethasone by simple physisorption, presumably accomplished by hydrogen bonding formation and/or complexation with sodium counterions, as shown by solid state NMR. The physisorption can be somehow modulated by changing the solvent in the adsorption process. This simple system is able to deliver dexamethasone in a controlled manner to solutions used as models for vitreous humor. The proven biocompatibility of laponite as well as its transparency in the gel state, together with the simplicity of the preparation method, makes this system suitable for future in vivo tests of ophthalmic treatment.This study was supported by the Instituto de Salud Carlos III (project PI12/02285) and authors would like to acknowledge the financial support received from Diputación General de Aragón (E11 Group co-financed by the European Regional Development Funds).Peer Reviewe